ADVISORY, April 06, 2017 (GLOBE NEWSWIRE) --
Society for Science & the Public and Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will visit the Nasdaq MarketSite in Times Square with the top winners of the 2017 Regeneron Science Talent Search, the nation’s oldest and most prestigious science and math competition for high school seniors. Finalists were selected based on the scientific rigor and world-changing potential of their research projects.
In honor of the occasion, George D. Yancopoulos, MD, PhD, President & Chief Scientific Officer, Regeneron, Maya Ajmera, President & CEO, Society for Science & the Public & Publisher of Science News, and Winner of Regeneron Science Talent Search, will ring the Closing Bell.
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
Friday, April 7, 2017 – 3:45 p.m. to 4:00 p.m. ET
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page:
For photos from ceremonies and events, please visit our Instagram page:
For livestream of ceremonies and events, please visit our YouTube page:
For news tweets, please visit our Twitter page:
For exciting viral content and ceremony photos, please visit our Tumblr page:
A live stream of the Nasdaq Closing Bell will be available at:
To obtain a hi-resolution photograph of the Market Close, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market close of your choice.
About the Regeneron Science Talent Search
The Regeneron Science Talent Search, a program of Society for Science & the Public since 1942, is the nation’s oldest and most prestigious science and math competition for high school seniors. Each year, approximately 1,700 student entrants to the Science Talent Search submit original research in critically important scientific fields of study and are judged by leading experts in their fields. Unique among high school competitions in the U.S. and globally, the Regeneron Science Talent Search focuses on identifying the next generation of scientists and engineers who will provide critical leadership in solving some of the world's most pressing challenges while shaping the future of research and development for our nation and the world.
As part of its 10-year, $100 million commitment, Regeneron has significantly increased awards to better reward the best and brightest young talent and encourage their continued pursuit of scientific innovation. Regeneron has nearly doubled the overall award distribution to $3.1 million annually, and increased the top award to $250,000. As a key component of the Regeneron sponsorship, $30 million will be dedicated to supporting initiatives focused on increasing outreach and equity for students across the United States to nurture their interest in the sciences. This funding will support programming designed to reach new and underprivileged communities, support teachers and inspire more students to pursue science research and STEM careers.
Program alumni include recipients of the world's most coveted science and math honors, including eleven National Medals of Science, four Breakthrough Prizes, eighteen MacArthur Foundation Fellowships, two Fields Medals and twelve Nobel Prizes. Distinguished Science Talent Search alumni include Society Trustees Mary Sue Coleman (president emeritus, University of Michigan), Tom Leighton (co-founder and CEO, Akamai Technologies), Paul Maddon (founder of Progenics) and Frank Wilczek (2004 Nobel Prize in Physics), among many others.
Intel was the title sponsor of the Science Talent Search from 1998-2016. For the first 55 years (1942-1997) of the Science Talent Search, Westinghouse was the title sponsor.
About Society for Science & the Public
Society for Science & the Public is dedicated to the achievement of young scientists in independent research and to public engagement in science. Established in 1921, Society is a nonprofit whose vision is to promote the understanding and appreciation of science and the vital role it plays in human advancement. Through its world-class competitions, including the Regeneron Science Talent Search, the Intel International Science and Engineering Fair, and the Broadcom MASTERS, and its award-winning magazine, Science News and Science News for Students, Society for Science & the Public is committed to inform, educate, and inspire. Learn more at www.societyforscience.org and follow us on Facebook, Twitter, Instagram and Snapchat (Society4Science).
About Regeneron Pharmaceuticals, Inc.
Regeneron (NASDAQ:REGN) is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL cholesterol and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, atopic dermatitis, asthma, pain, cancer and infectious diseases. For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables clients to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 85 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,800 listed companies with a market value of $10.1 trillion and nearly 18,000 corporate clients. To learn more, visit: business.nasdaq.com.